Loading clinical trials...

Irisin Expression and Gene Polymorphism in Type II Diabetic Patients With and Without CAD | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT04957823

Irisin Expression and Gene Polymorphism in Type II Diabetic Patients With and Without CAD

This is an observertional study aimed at Study the association between the level of irisin expression and (Fibronectin Type III Domain Containing 5 (FDNC5) gene polymorphism and the presence and sever...

Lead sponsor: Sohag University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment100

Start dateApr 2021

Last updatedFeb 29, 2024

Condition

Irisin Gene Polymorphism in Type II Diabetic Patients

Locations shown

Sohag uniersity hosoital

Sohag

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 29, 2024Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions